Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 12.12
+0.24 (2.02%)
At close: May 6, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 564.04 million as of May 6, 2026. Its market cap has increased by 13.27% in one year.
Market Cap
564.04M
Enterprise Value
84.68M
Revenue
57.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.12
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 564.04M, a decrease of -62.83%. That is a compound annual growth rate of -41.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 552.87M | -38.32% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.01B |
| Cereno Scientific AB | 1.90B |
| EQL Pharma AB | 1.47B |
| Orexo AB | 658.62M |
| Enzymatica AB | 616.55M |
| Dicot Pharma AB | 601.20M |
| Nanexa AB | 564.53M |
| Moberg Pharma AB | 540.51M |